Terns Pharmaceuticals, Inc. (TERN)

37.02 +0.42 (+1.15%) USD  |  NASDAQ  |  Jan 20, 13:46
More

Terns Pharmaceuticals Operating Income (Quarterly)

Operating Income (Quarterly) Chart

View Operating Income (Quarterly) for TERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly) Range, Past 5 Years

View Operating Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly) Benchmarks

View Operating Income (Quarterly) Benchmarks
Start Trial
Altimmune, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade